Literature DB >> 3458952

Histologic aspects of concomitant resistance induced by nonimmunogenic murine tumors.

R P Meiss, R D Bonfil, R A Ruggiero, C D Pasqualini.   

Abstract

Concomitant resistance to a second tumor implant was induced in both conventional and nude BALB/c mice by two nonimmunogenic syngeneic tumors of spontaneous origin, an epidermoid carcinoma and a lymphoid leukemia. In the secondary tumor, which was significantly inhibited by concomitant resistance, histologic examination revealed the presence of well-preserved tumor cells without any sign of necrosis and without any host cell infiltration, contrasting with classical immunologic rejection. Tumor cell proliferation as evaluated by the number of mitoses per high-power field was significantly inhibited in the secondary tumor as compared with the corresponding controls. No effect of concomitant resistance could be detected on primary tumor growth.

Entities:  

Mesh:

Year:  1986        PMID: 3458952

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  10 in total

1.  Murine T cell leukemia line in suspension culture.

Authors:  C Mongini; C Waldner; I Roig; S E Hajos
Journal:  In Vitro Cell Dev Biol       Date:  1991-07

2.  Tumor necrosis can facilitate the appearance of metastases.

Authors:  R D Bonfil; O D Bustuoabad; R A Ruggiero; R P Meiss; C D Pasqualini
Journal:  Clin Exp Metastasis       Date:  1988 Mar-Apr       Impact factor: 5.150

3.  Biphasic effect of a primary tumor on the growth of secondary tumor implants.

Authors:  Juan Bruzzo; Paula Chiarella; Roberto P Meiss; Raúl A Ruggiero
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-21       Impact factor: 4.553

4.  Angiogenic and antiangiogenic balance regulates concomitant antitumoral resistance.

Authors:  O Graciela Scharovsky; M Mercedes Binda; Viviana R Rozados; Sunita Bhagat; Michael L Cher; R Daniel Bonfil
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

5.  Anti-inflammation induced by counter-irritation or by treatment with non-steroidal agents inhibits the growth of a tumour of non-detected immunogenicity.

Authors:  D O Sordelli; P A Fontán; R P Meiss; R A Ruggiero; O D Bustuoabad
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

6.  Improvement of Antitumor Therapies Based on Vaccines and Immune-Checkpoint Inhibitors by Counteracting Tumor-Immunostimulation.

Authors:  Paula Chiarella; Mónica Vermeulen; Daniela R Montagna; Pablo Vallecorsa; Ariel Ramiro Strazza; Roberto P Meiss; Oscar D Bustuoabad; Raúl A Ruggiero; Richmond T Prehn
Journal:  Front Oncol       Date:  2018-01-26       Impact factor: 6.244

7.  A serum-mediated mechanism for concomitant resistance shared by immunogenic and non-immunogenic murine tumours.

Authors:  M Franco; O D Bustuoabad; P D di Gianni; A Goldman; C D Pasqualini; R A Ruggiero
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

8.  Game-changing restraint of Ros-damaged phenylalanine, upon tumor metastasis.

Authors:  Geraldine Gueron; Nicolás Anselmino; Paula Chiarella; Emiliano G Ortiz; Sofia Lage Vickers; Alejandra V Paez; Jimena Giudice; Mario D Contin; Daiana Leonardi; Felipe Jaworski; Verónica Manzano; Ariel Strazza; Daniela R Montagna; Estefania Labanca; Javier Cotignola; Norma D Accorso; Anna Woloszynska-Read; Nora Navone; Roberto P Meiss; Raúl Ruggiero; Elba Vazquez
Journal:  Cell Death Dis       Date:  2018-02-02       Impact factor: 8.469

9.  Antitumor effect of PSK: role of regional lymph nodes and enhancement of concomitant and sinecomitant immunity in the mouse.

Authors:  T Ebina; H Kohya; K Ishikawa
Journal:  Jpn J Cancer Res       Date:  1989-02

10.  Antitumor effector mechanism at a distant site in the double grafted tumor system of PSK, a protein-bound polysaccharide preparation.

Authors:  T Ebina; H Kohya
Journal:  Jpn J Cancer Res       Date:  1988-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.